Awardee OrganizationUNIVERSITY OF CALIFORNIA LOS ANGELES
Description
Abstract Text
Quantitative image features (QIFs) such as radiomic and deep features hold enormous potential to improve the
detection, diagnosis, and treatment assessment of a wide range of diseases. Generated from clinically acquired
Computed Tomography (CT) scans, QIFs represent small pixel-wise changes that may be early indicators of
disease progression. However, detecting these changes is complicated by variations in how CT scans are
acquired and reconstructed. Ensuring repeatable and reproducible QIFs is necessary for developing predictive
models that achieve consistent performance across different clinical settings. This project's premise is that QIFs
are sensitive to CT parameters such as radiation dose level, slice thickness, reconstruction kernel, and
reconstruction method. The combined interactions among these parameters result in unique image conditions,
each yielding its own QIF value. Moreover, some clinical tasks and algorithms are more sensitive to differences
in QIF values than others. We hypothesize that a systematic, task-dependent framework to characterize the
impact of variability in CT parameters and effectively mitigate them will result in more consistent QIF values and
the performance of prediction models. Three interrelated innovations will be pursued in this work: 1) a novel
framework for characterizing the impact of different acquisition and reconstruction parameters on QIFs
and ML models using patient scans with known clinical outcomes in multiple domains; 2) a systematic
approach for selecting an optimal mitigation technique and evaluating the impact of normalization; and
3) an open-source software toolkit that formalizes the process of CT normalization, addressing real-
world use cases developed by academic and industry collaborators. In Aim 1, we will evaluate how multiple
CT parameters influence QIF values and model performance. Utilizing metrics of agreement and a heat map-
based visualization, we will determine under which image acquisition and reconstruction conditions the QIFs and
model performance are consistent. In Aim 2, we will assess and enhance normalization techniques for mitigating
the impact of differences in acquisition and reconstruction, targeting the set of imaging conditions that are most
relevant to a clinical task. In Aim 3, we will engage a spectrum of external stakeholders to guide the development
and adoption of a software toolkit called CT-NORM. Three distinct clinical domains will drive our efforts: lung
nodule detection (which relies on identifying small regions of high contrast differences to identify nodules),
interstitial lung disease quantification (which depends on characterizing texture differences), and ischemic core
assessment (which relies on detecting low contrast differences in brain tissue). CT-NORM will provide the
scientific community with an approach and a unified toolkit to characterize and mitigate the impact of
reconstruction and acquisition parameters on QIFs and prediction model performance. By addressing critical
sources of variability, we will improve the process of generating QIFs and facilitate the discovery of precise and
reproducible imaging phenotypes of disease.
Public Health Relevance Statement
PROJECT NARRATIVE
Computed Tomography (CT) images play an integral role in screening and diagnosing lung cancer, interstitial
lung disease, and stroke. While quantitative image features can facilitate accurate characterization of diseases,
these features are highly sensitive to variations in how the CT images are acquired and reconstructed, negatively
impacting their reproducibility and the performance of machine learning models that utilize these features. This
project investigates the effects of varying CT parameters on these image-derived features and uses that infor-
mation to identify optimal techniques to mitigate their effects in a task-dependent manner.
National Institute of Biomedical Imaging and Bioengineering
CFDA Code
286
DUNS Number
092530369
UEI
RN64EPNH8JC6
Project Start Date
01-September-2022
Project End Date
31-May-2025
Budget Start Date
01-June-2024
Budget End Date
31-May-2025
Project Funding Information for 2024
Total Funding
$591,491
Direct Costs
$402,761
Indirect Costs
$188,730
Year
Funding IC
FY Total Cost by IC
2024
National Institute of Biomedical Imaging and Bioengineering
$591,491
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R01EB031993-03
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01EB031993-03
Patents
No Patents information available for 5R01EB031993-03
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01EB031993-03
Clinical Studies
No Clinical Studies information available for 5R01EB031993-03
News and More
Related News Releases
No news release information available for 5R01EB031993-03
History
No Historical information available for 5R01EB031993-03
Similar Projects
No Similar Projects information available for 5R01EB031993-03